Literature DB >> 10879284

MHC class II-restricted antigen processing and presentation.

J Pieters1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10879284     DOI: 10.1016/s0065-2776(00)75004-8

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  35 in total

1.  Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules.

Authors:  Suk-Jo Kang; Peter Cresswell
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

Review 2.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

3.  Physical and genetic mapping of the rainbow trout major histocompatibility regions: evidence for duplication of the class I region.

Authors:  Ruth B Phillips; Ana Zimmerman; Marc A Noakes; Yniv Palti; Matt R W Morasch; Lisa Eiben; Sandra S Ristow; Gary H Thorgaard; John D Hansen
Journal:  Immunogenetics       Date:  2003-10-18       Impact factor: 2.846

4.  Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles.

Authors:  Pedro A Reche; John-Paul Glutting; Hong Zhang; Ellis L Reinherz
Journal:  Immunogenetics       Date:  2004-09-03       Impact factor: 2.846

5.  Polarized expression of CD74 by gastric epithelial cells.

Authors:  Carlos A Barrera; Ellen J Beswick; Johanna C Sierra; David Bland; Rosario Espejo; Randy Mifflin; Patrick Adegboyega; Sheila E Crowe; Peter B Ernst; Victor E Reyes
Journal:  J Histochem Cytochem       Date:  2005-05-27       Impact factor: 2.479

6.  Increased proteolysis of diphtheria toxin by human monocytes after heat shock: a subsidiary role for heat-shock protein 70 in antigen processing.

Authors:  Barbara S Polla; Françoise Gabert; Brigitte M-N Peyrusse; Muriel R Jacquier-Sarlin
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

7.  Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.

Authors:  Holger Rüssmann; Klaus Panthel; Brigitte Köhn; Stefan Jellbauer; Sebastian E Winter; Sara Garbom; Hans Wolf-Watz; Sigrid Hoffmann; Silke Grauling-Halama; Gernot Geginat
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

8.  MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells.

Authors:  Minu K Srivastava; Jacobus J Bosch; Ashley L Wilson; Martin J Edelman; Suzanne Ostrand-Rosenberg
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

9.  Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.

Authors:  Michael Schindler; Stephanie Würfl; Philippe Benaroch; Thomas C Greenough; Rod Daniels; Philippa Easterbrook; Matthias Brenner; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells.

Authors:  Nagendra R Hegde; David C Johnson
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.